These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6312608

  • 21. Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition.
    Carty TJ, Stevens JS, Lombardino JG, Parry MJ, Randall MJ.
    Prostaglandins; 1980 May; 19(5):671-82. PubMed ID: 6775350
    [Abstract] [Full Text] [Related]

  • 22. The effect of piroxicam and auranofin on cell migration.
    Rueda HA, Scheinberg MA.
    Clin Rheumatol; 1985 Mar; 4(1):68-72. PubMed ID: 3921306
    [Abstract] [Full Text] [Related]

  • 23. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
    Ward PA, Sulavik MC, Johnson KJ.
    Am J Pathol; 1984 Aug; 116(2):223-33. PubMed ID: 6087668
    [Abstract] [Full Text] [Related]

  • 24. Prostaglandin-independent inhibition of calcium transport by nonsteroidal anti-inflammatory drugs: differential effects of carboxylic acids and piroxicam.
    Burch RM, Wise WC, Halushka PV.
    J Pharmacol Exp Ther; 1983 Oct; 227(1):84-91. PubMed ID: 6312024
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of in vitro neutrophil responses to chemotactic factors by piroxicam.
    Tanaka K, Kanaoka K, Egawa M, Abe N, Watanabe I, Hirai S.
    Jpn J Pharmacol; 1984 Jun; 35(2):181-91. PubMed ID: 6611436
    [Abstract] [Full Text] [Related]

  • 26. Pathogenesis of inflammation. Effects of the pharmacological manipulation of arachidonic acid metabolism on the cytological response to inflammatory stimuli.
    Weissmann G.
    Drugs; 1987 Jun; 33 Suppl 1():28-37. PubMed ID: 3036461
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of low doses of methotrexate on superoxide anion production by polymorphonuclear leukocytes from patients with rheumatoid arthritis.
    Laurindo IM, Mello SB, Cossermelli W.
    J Rheumatol; 1995 Apr; 22(4):633-8. PubMed ID: 7791154
    [Abstract] [Full Text] [Related]

  • 29. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs.
    Díaz-González F, González-Alvaro I, Campanero MR, Mollinedo F, del Pozo MA, Muñoz C, Pivel JP, Sánchez-Madrid F.
    J Clin Invest; 1995 Apr; 95(4):1756-65. PubMed ID: 7535797
    [Abstract] [Full Text] [Related]

  • 30. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
    Bozza PT, Payne JL, Morham SG, Langenbach R, Smithies O, Weller PF.
    Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):11091-6. PubMed ID: 8855314
    [Abstract] [Full Text] [Related]

  • 31. Effect of antiinflammatory agents on neutrophil superoxide production in rheumatoid arthritis.
    Spisani S, Marangoni C, Dovigo L, Traniello S.
    Inflammation; 1984 Mar 01; 8(1):45-52. PubMed ID: 6325344
    [Abstract] [Full Text] [Related]

  • 32. Circadian variations in the superoxide production, enzyme release and neutrophil aggregation in patients with rheumatoid arthritis and controls.
    Muniain MA, Rodríguez MD, Romero A, Mata R, Vargas C, Naranjo A.
    Br J Rheumatol; 1991 Apr 01; 30(2):138-40. PubMed ID: 1849434
    [Abstract] [Full Text] [Related]

  • 33. Nonsteroidal anti-inflammatory drugs and immunologic function. Overview of the European experience.
    Bacon PA.
    Am J Med; 1984 Oct 15; 77(4B):26-31. PubMed ID: 6238529
    [Abstract] [Full Text] [Related]

  • 34. Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels.
    Goodwin JS, Ceuppens JL, Rodriguez MA.
    JAMA; 1983 Nov 11; 250(18):2485-8. PubMed ID: 6226809
    [Abstract] [Full Text] [Related]

  • 35. Association of enhanced superoxide generation by neutrophils with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting anti-rheumatic drugs and disease activity.
    Prónai L, Ichikawa Y, Ichimori K, Nakazawa H, Arimori S.
    Clin Exp Rheumatol; 1991 Nov 11; 9(2):149-55. PubMed ID: 1647912
    [Abstract] [Full Text] [Related]

  • 36. Effects of piroxicam on mononuclear cells. Comparison with other antiarthritic drugs.
    Gordon D, Lewis GP.
    Inflammation; 1984 Jun 11; 8 Suppl():S87-102. PubMed ID: 6332779
    [Abstract] [Full Text] [Related]

  • 37. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo.
    Kaplan HB, Edelson HS, Korchak HM, Given WP, Abramson S, Weissmann G.
    Biochem Pharmacol; 1984 Feb 01; 33(3):371-8. PubMed ID: 6422946
    [Abstract] [Full Text] [Related]

  • 38. Effects of nonsteroidal antiinflammatory drugs on the immune network.
    Førre O, Thoen J, Natvig JB.
    Semin Arthritis Rheum; 1983 Aug 01; 13(1 Suppl 1):130-3. PubMed ID: 6353582
    [Abstract] [Full Text] [Related]

  • 39. Non-steroidal anti-inflammatory agent inhibit the synthesis of IgM rheumatoid factor in vitro.
    Ceuppens JL, Rodriguez MA, Goodwin JS.
    Lancet; 1982 Mar 06; 1(8271):528-30. PubMed ID: 6120390
    [Abstract] [Full Text] [Related]

  • 40. Effects of tenoxicam, a new anti-inflammatory drug, on in vitro neutrophil activation.
    Laghi Pasini F, Capecchi PL, Ceccatelli L, Orrico A, Pasqui AL, Di Perri T.
    Boll Chim Farm; 1985 Nov 06; 124(11):477-82. PubMed ID: 3833264
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.